European Disease Progression Monitor: Edition 4

The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies

L.E.K. has identified 5 phases of disease progression, defined by the death rate, with the possibility of repeated cycles if countries suffer viral…

Weekly focus – A consistent pattern of lockdown exit strategies is emerging, with an initial focus on reopening childcare and small retail businesses.

Each week we will update our staff and clients with metrics to track disease progression

We discuss some of the innovative funding models available and identify the key strategies for optimizing these types of deals.

The biopharma industry has accelerated research and development (R&D) timelines. However, therapeutics/vaccines in development are projected to launch…